Eribulin Mesylate
99%
- Product Code: 51956
CAS:
441045-17-6
| Molecular Weight: | 826.0 g./mol | Molecular Formula: | C₄₀H₅₉NO₁₁CH₄O₃S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, protected from light, stored in an inert gas |
Product Description:
Eribulin mesylate is primarily used in the treatment of metastatic breast cancer, particularly for patients who have previously undergone at least two chemotherapy regimens. It works by inhibiting the growth phase of microtubules, which are essential for cell division, thereby slowing or stopping the proliferation of cancer cells. This makes it a valuable option for managing advanced stages of the disease where other treatments have failed. Additionally, it has shown efficacy in treating liposarcoma, a rare type of soft tissue sarcoma, offering an alternative for patients with limited therapeutic options. Its ability to improve overall survival rates in these conditions underscores its importance in oncology.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white Solid |
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 500.000 | 10-20 days | ฿180,000.00 |
+
-
|
Eribulin Mesylate
Eribulin mesylate is primarily used in the treatment of metastatic breast cancer, particularly for patients who have previously undergone at least two chemotherapy regimens. It works by inhibiting the growth phase of microtubules, which are essential for cell division, thereby slowing or stopping the proliferation of cancer cells. This makes it a valuable option for managing advanced stages of the disease where other treatments have failed. Additionally, it has shown efficacy in treating liposarcoma, a rare type of soft tissue sarcoma, offering an alternative for patients with limited therapeutic options. Its ability to improve overall survival rates in these conditions underscores its importance in oncology.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :